Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Farrell

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Pharmacology & Therapeutics|January 1, 1987
Drug metabolism in extrahepatic diseasesG C Farrell
Australian and New Zealand Journal of Medicine|August 1, 1988
Towards the eradication of hepatitis B in AustraliaG C Farrell
Digestive Diseases and Sciences|December 1, 1996
Two years versus six months of interferon therapy for chronic hepatitis CG C Farrell
Journal of Gastroenterology and Hepatology|September 11, 1999
Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?G C Farrell
Drugs|November 21, 2000
Clinical potential of emerging new agents in hepatitis BG C Farrell
Australian Family Physician|March 1, 1995
Hepatitis C: a current perspectiveG C Farrell
The Medical Journal of Australia|January 31, 1976
Fanconi's familial hypoplastic anaemia with some unusual featuresG C Farrell
Journal of Gastroenterology and Hepatology|January 1, 1991
Treatment of chronic hepatitis C with alpha-interferonG C Farrell
The Medical Journal of Australia|December 1, 1986
The hepatic side-effects of drugsG C Farrell
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: interferon alfa-n1 trialsG C Farrell
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Pharmacology & Therapeutics|January 1, 1987
Drug metabolism in extrahepatic diseasesG C Farrell
Australian and New Zealand Journal of Medicine|August 1, 1988
Towards the eradication of hepatitis B in AustraliaG C Farrell
Digestive Diseases and Sciences|December 1, 1996
Two years versus six months of interferon therapy for chronic hepatitis CG C Farrell
Journal of Gastroenterology and Hepatology|September 11, 1999
Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?G C Farrell
Drugs|November 21, 2000
Clinical potential of emerging new agents in hepatitis BG C Farrell
Australian Family Physician|March 1, 1995
Hepatitis C: a current perspectiveG C Farrell
The Medical Journal of Australia|January 31, 1976
Fanconi's familial hypoplastic anaemia with some unusual featuresG C Farrell
Journal of Gastroenterology and Hepatology|January 1, 1991
Treatment of chronic hepatitis C with alpha-interferonG C Farrell
The Medical Journal of Australia|December 1, 1986
The hepatic side-effects of drugsG C Farrell
Hepatology (Baltimore, Md.)|September 26, 1997
Therapy of hepatitis C: interferon alfa-n1 trialsG C Farrell
Pageof 17